Baird Medical Investment Holdings (BDMD) Common Equity (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Common Equity data on file, last reported at $31.2 million in Q4 2025.

• On a quarterly basis, Common Equity fell 21.47% year-over-year to $31.2 million in Q4 2025; TTM through Dec 2025 was $31.2 million, a 21.47% decrease from a year earlier, with the FY2025 full-year figure at $31.2 million, down 21.47% from the prior year.
• Common Equity for Q4 2025 stood at $31.2 million, down from $35.6 million in the prior quarter.
• Over the last five years, Common Equity for BDMD reached as high as $39.8 million in Q4 2024 and fell as low as $31.2 million in Q4 2025.
• Historically, Common Equity has averaged $35.6 million across 3 years, with a median of $35.7 million in 2023.
• Across the five-year window, Common Equity climbed 11.35% in 2024 and fell 21.47% in 2025, its largest moves.
• Year by year, Common Equity stood at $35.7 million in 2023, then climbed by 11.35% to $39.8 million in 2024, then fell by 21.47% to $31.2 million in 2025.
• Per Business Quant data, the three most recent Common Equity figures were $31.2 million in Q4 2025, $35.6 million in Q2 2025, and $39.8 million in Q4 2024.